TTop stories Read More FDA’s top drug regulator resigns after federal officials probe ‘serious concerns’November 3, 2025 WASHINGTON (AP) — The head of the Food and Drug Administration’s drug center abruptly resigned Sunday after federal…
TTop stories Read More FDA vaccine chief Vinay Prasad leaves following criticism from Laura LoomerJuly 30, 2025 WASHINGTON (AP) — The Food and Drug Administration’s polarizing vaccine chief is leaving the agency after a brief…
TTop stories Read More Sarepta stock falls on FDA gene therapy Elevidys commentJuly 18, 2025 Douglas Ingram, president and chief executive officer of Sarepta Therapeutics Inc., during the Forbes Healthcare Summit in New…